Corticosteroid replacement by ruxolitinib in patients with acute GVHD experiencing severe steroid-induced side effects. [electronic resource]
Producer: 20210621Description: 253-255 p. digitalISSN:- 1476-5365
No physical items for this record
Publication Type: Letter
There are no comments on this title.
Log in to your account to post a comment.